Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
may be a member of the chemokine receptor family [RGD, Feb 2006].. Additionally we are shipping CMKLR1 Kits (5) and CMKLR1 Proteins (4) and many more products for this protein.
Showing 10 out of 125 products:
Human Polyclonal CMKLR1 Primary Antibody for WB - ABIN1881215
Ohira, Arita, Omori, Recchiuti, Van Dyke, Serhan: Resolvin E1 receptor activation signals phosphorylation and phagocytosis. in The Journal of biological chemistry 2010
Show all 5 references for ABIN1881215
Mouse (Murine) Monoclonal CMKLR1 Primary Antibody for FACS - ABIN2663667
Owman, Lolait, Santén, Olde: Molecular cloning and tissue distribution of cDNA encoding a novel chemoattractant-like receptor. in Biochemical and biophysical research communications 1998
Show all 3 references for ABIN2663667
Mouse (Murine) Polyclonal CMKLR1 Primary Antibody for IF (p), IHC (p) - ABIN1715118
Qu, Zhang, Yao, Song, Nikolic-Paterson, Li: Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation. in The Journal of pathology 2014
Show all 2 references for ABIN1715118
Mouse (Murine) Polyclonal CMKLR1 Primary Antibody for WB - ABIN2792203
Samson, Edinger, Stordeur, Rucker, Verhasselt, Sharron, Govaerts, Mollereau, Vassart, Doms, Parmentier: ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains. in European journal of immunology 1998
Human Monoclonal CMKLR1 Primary Antibody for FACS - ABIN4895587
Herová, Schmid, Gemperle, Hersberger: ChemR23, the receptor for chemerin and resolvin E1, is expressed and functional on M1 but not on M2 macrophages. in Journal of immunology (Baltimore, Md. : 1950) 2015
CMKLR1 gene deletion attenuates the effects of chronic DHT treatment on ovarian function in experimental PCOS, likely via BMP4 (show BMP4 Antibodies) signaling.
Loss of CMKLR1 exacerbates glucose intolerance and insulin (show INS Antibodies) resistance in mice fed high fat diets.
The chemerin15 (C15) precursor, chemerin, and its receptor, ChemR23, are both upregulated after skin damage and the receptor is expressed by macrophages, neutrophils, and keratinocytes. C15 delivery dampens immediate inflammatory events.
Results indicate that Abeta42 activates CMKLR1, leading to glia cell migration and clearance of Abeta42; and is involved in Abeta (show APP Antibodies) processing and clearance
Increased chemerin (show RARRES2 Antibodies) expression in dermal blood vessels may be associated with the development of digital ulcers in systemic sclerosis.
In brown adipose tissue, cold acclimation strongly diminished chemerin (show RARRES2 Antibodies) gene expression, whereas obesogenic diets augmented expression.
Hematopoietic Deletion of Cmklr1 Does not Affect the Development of Insulin (show INS Antibodies) Resistance or nonalcoholic fatty liver disease.
ChemR23 is expressed in neutrophil granules and rapidly upregulated upon neutrophil activation.
Development of a membrane-anchored chemerin receptor agonist as a novel modulator of allergic airway inflammation and neuropathic pain.
Data suggest that chemerin (show RARRES2 Antibodies)/ChemR23 signaling is not essential for adipocyte differentiation, but it appears to play a role in control of body weight and energy metabolism as overweight/obesity progresses.
Our results show that higher levels of circulating chemerin (show RARRES2 Antibodies), CRP (show CRP Antibodies), fibrinogen, and ESR (show ESR1 Antibodies) are associated with an increased risk of developing colorectal cancer
Data show inverse Relationship of the CMKLR1 Relative Expression and Chemerin (show RARRES2 Antibodies) Serum Levels in Obesity with Dysmetabolic Phenotype and Insulin (show INS Antibodies) Resistance
RAGE has been identified as a novel binding protein for BLT1; RAGE modulates downstream signaling from BLT1 and affects cell migration through BLT1 both in vitro and in vivo.
Induction of pSmad3L through BLT1-NOX-ROS (show ROS1 Antibodies)-EGFR (show EGFR Antibodies)-PI3K (show PIK3CA Antibodies)-ERK1/2 (show MAPK1/3 Antibodies) signaling pathway is a key mechanism by which LTB4 (show PTGR1 Antibodies) blocks the anti-proliferative responses of TGF-beta1 (show TGFB1 Antibodies) in breast tumors.
pro-inflammatory stimuli lead to FPR2 (show FPR2 Antibodies)/ALX expression while LXA4 induces an anti-inflammatory response
The BLT1 Inhibitory Function of alpha-1 Antitrypsin (show SERPINA1 Antibodies) Augmentation Therapy Disrupts Leukotriene B4 Neutrophil Signaling.
Gestational obesity and gestational diabetes mellitus may contribute to elevated serum chemerin (show RARRES2 Antibodies). Serum chemerin (show RARRES2 Antibodies) in pregnancy was associated with insulin (show INS Antibodies) resistance and triglycerides. Chemerin (show RARRES2 Antibodies) gene may play a role both in obese and gestational diabetes mellitus patients
The study for the first time confirmed a marked expression of chemerin (show RARRES2 Antibodies) and CMKLR1 in the liver of chronic hepatitis patients.
may be a member of the chemokine receptor family
chemokine-like receptor 1
, G-protein coupled receptor 27
, G-protein coupled receptor DEZ
, chemerin receptor
, chemokine receptor-like 1
, G-protein coupled chemoattractant-like receptor
, G-protein coupled receptor ChemR23
, orphan G-protein coupled receptor, Dez
, resolvin E1 receptor
, seven transmembrane helix receptor
, G protein-coupled receptor 16
, G-protein coupled receptor 16
, LTB4-R 1
, P2Y purinoceptor 7
, chemoattractant receptor-like 1
, leukotriene B4 receptor 1
, purinergic receptor P2Y, G-protein coupled, 7